Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results, Provide Corporate Update and Host Conference Call

Rhea-AI Summary

Corcept Therapeutics (NASDAQ: CORT) is set to release its fourth quarter and full-year 2022 financial results on February 28, 2023. The announcement will be accompanied by a corporate update and a conference call at 5:00 p.m. ET (2:00 p.m. PT). To participate, dial 877-407-8029 from the U.S. or +1-201-689-8029 internationally. A replay of the call will be accessible on the company’s website.

Corcept is known for its proprietary cortisol modulators, including its FDA-approved drug Korlym®, used to treat Cushing’s syndrome.

MENLO PARK, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2022 financial results and provide a corporate update on February 28, 2023. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time).

Conference Call Information
To access the conference call, please dial 877-407-8029 from the United States or +1-201-689-8029 internationally.

A replay of the call will be available on the Investors / Events tab of www.corcept.com.

About Corcept Therapeutics
Corcept has discovered a large portfolio of proprietary compounds that selectively modulate the effects of cortisol and owns extensive United States and foreign intellectual property covering both their composition and their use to treat a variety of serious disorders. The company is conducting clinical trials of its leading cortisol modulators as potential treatments for patients with Cushing’s syndrome, ovarian, prostate and adrenal cancer, ALS and liver disease. Corcept’s drug Korlym® was the first medication approved by the U.S. Food and Drug Administration for the treatment of patients with Cushing’s syndrome.

CONTACT:
Corcept Therapeutics
Investor Relations
ir@corcept.com
www.corcept.com

FAQ

When will Corcept Therapeutics announce its 2022 financial results?

Corcept Therapeutics will announce its 2022 financial results on February 28, 2023.

What time is the Corcept Therapeutics conference call?

The conference call will be held at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time) on February 28, 2023.

How can I access the conference call for Corcept Therapeutics?

To access the conference call, dial 877-407-8029 from the U.S. or +1-201-689-8029 internationally.

What is Korlym® used for?

Korlym® is an FDA-approved medication for the treatment of patients with Cushing’s syndrome.